Recruiting

Observational Study

Sponsor:

University of Washington

Code:

NCT06672835

Conditions

Mental Health

Health Services

Evidence Based Programs in Schools

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

eBASIS

eAttention Control

Study Details

Brief summary:

The objective of the BASIS R34 pilot study is to test the impact of eBASIS in a randomized controlled trial (RCT). Consistent with IMPACT's IQM, the study tests effects of eBASIS on treatment fidelity and youth outcomes, compared to a digitally delivered control (N=32 clinicians; 96 clients). A well-established EBP (Cognitive Behavioral Therapy Plus), will be a focus of the investigation, which eligible participants will already be signed up to receive.

Conditions

Mental Health

Health Services

Evidence Based Programs in Schools

Study ID

NCT06672835

Start date

Oct 5, 2024

Status verified date

Apr, 2026

Completion date

Jul 30, 2026

Anticipated

Primary completion date

Jul 30, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Mental health provider who spends 2 hours or more providing supports in school setting
  • Registered to receive CBT+ training from the WA State EBP Initiative

Exclusion Criteria:

  • None

Study Design

Enrollment

32 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: eBASIS

eBASIS is an online, optimized, and evidence-based practice agnostic implementation strategy that addresses the behavioral component often missing from standard evidence-based practice training and consultation. It relates to motivation before and volition after the evidence-based practice training and targets behavioral intentions by improving attitudes, subjective norms, and self-efficacy. The implementation strategy is designed to be designed to be delivered within the Preparation/Adoption phase immediately prior to the Action implementation in the EPIS model.

placebo comparator: eAttention Control

eAC is an online control for eBASIS. Providers assigned to eAttention Control (eAC) will receive pre- and post-training experiences designed to mirror those received in eBASIS. These training experiences will be delivered on the same platform and be approximately the same length as the eBASIS but will not contain any eBASIS content or mechanisms of change. The eAC pre-training experience will define, describe, and advocate for evidence-based practice implementation in schools. Content in eAC will be didactic similar to a typical professional development training for providers.

Interventions

eBASIS

eBASIS is an online, optimized, and evidence-based practice agnostic implementation strategy that addresses the behavioral component often missing from standard evidence-based practice training and consultation. It relates to motivation before and volition after the evidence-based practice training and targets behavioral intentions by improving attitudes, subjective norms, and self-efficacy. The implementation strategy is designed to be designed to be delivered within the Preparation/Adoption phase immediately prior to the Action implementation in the EPIS model.

eAttention Control

eAC is an online control for eBASIS. Providers assigned to eAttention Control (eAC) will receive pre- and post-training experiences designed to mirror those received in eBASIS. These training experiences will be delivered on the same platform and be approximately the same length as the eBASIS but will not contain any eBASIS content or mechanisms of change. The eAC pre-training experience will define, describe, and advocate for evidence-based practice implementation in schools. Content in eAC will be didactic similar to a typical professional development training for providers.

Primary outcome measure

  • Evidence-Based Practice Attitude Scale (EBPAS) [ Time Frame: Baseline, immediately after training, 2 weeks after training, 1 month after training, 2 months after training, 3 months after training ]
  • Subjective Norms [ Time Frame: Baseline, immediately after training, 2 weeks after training, 1 month after training, 2 months after training, 3 months after training ]
  • Outcome Expectancies [ Time Frame: Baseline, immediately after training, 2 weeks after training, 1 month after training, 2 months after training, 3 months after training ]
  • Action Self-Efficacy [ Time Frame: Baseline, immediately after training, 2 weeks after training, 1 month after training, 2 months after training, 3 months after training ]
  • Maintenance Self-Efficacy [ Time Frame: immediately after training, 2 weeks after training, 1 month after training, 2 months after training, 3 months after training ]
  • Perceived Needs [ Time Frame: Baseline, immediately after training, 2 weeks after training, 1 month after training, 2 months after training, 3 months after training ]
  • Modified Intention to Implement Scale (MIIS) [ Time Frame: Baseline, immediately after training, 2 weeks after training, 1 month after training, 2 months after training, 3 months after training ]
  • Intervention Usability Scale (IUS) [ Time Frame: immediately after training, 2 weeks after training, 1 month after training, 2 months after training, 3 months after training ]
  • Action Plan [ Time Frame: immediately after training, 2 weeks after training, 1 month after training, 2 months after training, 3 months after training ]
  • Coping Plan [ Time Frame: immediately after training, 2 weeks after training, 1 month after training, 2 months after training, 3 months after training ]

Central Contacts and Locations

Central contacts

Locations

University of Washington

Recruiting

Seattle, Washington, United States, 98115

Contacts

Principal Investigator:

Aaron Lyon, PhD

More Information

Sponsor

University of Washington

Last update posted

Apr 22, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Washington on 2026-04-22.